OM Pharma SA
Clinical trials sponsored by OM Pharma SA, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a daily powder cut wheezing attacks in toddlers? Results expected Sep 2026 (estimated)
-
Could a daily powder cut wheezing attacks in toddlers?
Disease control OngoingThis study tests whether a daily dose of OM-85, a bacterial extract mixed into food or drink, can reduce wheezing episodes in children aged 6 months to 5 years who have recurrent wheezing. About 296 children will receive either OM-85 or a placebo for 6 months. The goal is to see …
Phase 2 • Sponsor: OM Pharma SA • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New hope for wheezy tots: daily pill may cut infections
Prevention OngoingThis study tests whether OM-85 (Broncho-Vaxom), a bacterial extract taken by mouth for 10 days each month, can reduce the number of respiratory infections in children aged 6 months to 5 years who have a history of wheezing. About 525 children will receive either OM-85 or a placeb…
Phase 4 • Sponsor: OM Pharma SA • Aim: Prevention
Last updated Aug 05, 2026 00:00 UTC